Gosset Therapeutic Areas
Stage
Commercial
Modalities
Cresilon General Information
FDA-cleared hemostatic gel technology that stops bleeding within seconds through three mechanisms: holding pressure, activating platelets, and forming fibrin clots. Two approved products: VETIGEL for veterinary use and TRAUMAGEL for moderate to severe bleeding in humans.
Contact Information
Drug Pipeline
VETIGEL
CommercialKey Partnerships
Department of Defense
Cresilon Funding
| Deal Type | Date | Amount | Status | Stage |
|---|
To view Cresilon's complete valuation and funding history, request access »